Eastgate Biotech Corp. (ETBI)
OTCMKTS · Delayed Price · Currency is USD
0.0010
+0.0009 (900.00%)
At close: Feb 20, 2026
Eastgate Biotech Market Cap
Eastgate Biotech has a market cap or net worth of $1.06 million as of March 5, 2026. Its market cap has decreased by -74.36% in one year.
Market Cap
1.06M
Enterprise Value
n/a
Revenue
137.64K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 5, 2014, Eastgate Biotech's market cap has decreased from 7.91M to 1.06M, a decrease of -86.62%. That is a compound annual growth rate of -15.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.06M | -66.67% |
| Dec 18, 2025 | 3.17M | -33.33% |
| Dec 23, 2024 | 4.76M | 50.00% |
| Dec 30, 2022 | 3.17M | 11.11% |
| Dec 31, 2021 | 2.86M | -32.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entia Biosciences | 1.37M |
| Exousia Pro | 1.32M |
| Vaxxinity | 1.27M |
| Halberd | 1.23M |
| Evofem Biosciences | 1.15M |
| CERo Therapeutics Holdings | 1.14M |
| International Stem Cell | 1.13M |
| Sorrento Therapeutics | 1.03M |